BioCentury
ARTICLE | Company News

Corixa, Nycomed Amersham plc deal

November 5, 2001 8:00 AM UTC

Amersham Health, a business unit of NYE, will market Bexxar tositumomab, a monoclonal radiolabeled antibody against CD20 conjugated to iodine-131 in Europe to treat non-Hodgkin's Lymphoma (NHL). CRX...